Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 15, 2008Landmark trial provides new insight for physicians
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of the HORIZONS AMI trial. The HORIZONS AMI...
-
Oct 15, 2008
Boston Scientific Corporation (NYSE: BSX) today announced positive one-year results from the Intercontinental and European launch...
-
Oct 14, 2008New SYNTAX Score shows similar safety and efficacy outcomes for two thirds of study's patients
Boston Scientific Corporation (NYSE: BSX) today announced 12-month left main and three-vessel disease subset data from its landmark...
-
Oct 14, 2008Company moves up Q3 earnings release date
Boston Scientific Corporation (NYSE: BSX) today provided the following comments reinforcing the strength of its balance sheet: The volatility of...
-
Oct 14, 2008TAXUS® Atom™ in more than 500 accounts Company opening new PROMUS™ accounts
Boston Scientific Corporation (NYSE: BSX) today announced estimated U.S. market shares for September for its two drug-eluting stents (DES), based...
-
Oct 13, 2008Joint efforts will focus on intravascular ultrasound (IVUS)
GE Healthcare (NYSE: GE) and intravascular ultrasound (IVUS) market leader Boston Scientific Corporation (NYSE: BSX) today...
-
Oct 13, 2008
Thursday and Friday of last week saw continued heavy trading in Boston Scientific's (NYSE: BSX) stock. As anticipated in the Company's October 9th...
-
Oct 12, 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of nearly 7,500 patients from its TAXUS ARRIVE 1...
-
Oct 12, 2008New coronary stent features thin struts designed for more uniform drug delivery
Boston Scientific Corporation (NYSE: BSX) today announced comprehensive data from the TAXUS ATLAS clinical program, a series of...
-
Oct 10, 2008
Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its...